NORTH AMERICA MEDICAL THAWING SYSTEM MARKET FORECAST 2022-2030

The North America medical thawing system market growth is expected to progress at a CAGR of 7.37% during the forecast period, 2022-2030, recording a revenue of $138.81 million by 2030.

The region has the presence of several biotech & medical companies. Several major players in the global market are from North America. These include GE Healthcare, BioLife Solutions Inc, Meissner, Cardinal Health, etc. Also, the major cause of blood transfusion in the region is the rising number of car accidents. For instance, around 38680 deaths in 2019 were due to car accidents. Moreover, the North American medical thawing system market growth is attributed to the increasing acceptance of embryo freezing and sperm donation.

To know more about this report, request a free sample copy

Canada and the United States are evaluated for the North America medical thawing system market growth assessment. In 2021, the United States was the largest medical thawing system market globally. It is evaluated to remain a prominent consumer in the coming years. This is accredited to the extensive availability of government and capital support to the cell culture and biotech industries. Also, the country houses prominent market players. In addition, as per the Centers for Disease Control and Prevention (CDC), 6 in 10 adults have a chronic disease in the US, incurring $3.8 trillion in annual healthcare costs.

Further, almost 2400 institutions in the country encompassing hospital transfusion services, hospital blood banks, and community, ARC, and regional blood centers, provide blood for the needy patients. Besides, in 2020, the United States recorded the largest number of fatalities since 2007 (38680 deaths) as per the US Department of Transportation’s National Highway Traffic Safety Administration (NHTSA). Also, this projects an increase of around 7.2% in comparison to the fatalities reported in 2019.

Moreover, motor accidents and chronic diseases lead to massive blood loss, thereby needing a blood transfusion. Besides, employer-sponsored egg freezing is becoming increasingly common in the US. Facebook and Apple first introduced it in 2014. Currently, it is a work perk offered by almost 1 in 5 major US firms. Such aspects boost market demands in the United States.

The North America medical thawing system market segmentation includes the analysis of end-user and sample type. Ovum is a single cell released from either the female reproductive organ or the ovaries capable of developing into a new organism fertilized with a sperm cell. Egg freezing is a method of preserving the ability to get pregnant in the future. Eggs harvested from ovaries are stored and frozen unfertilized for later use. The thawing process aids in unfreezing the eggs for later use in the fertilization process.

Semen, fluid from the male reproductive tract, contains cells that are used to fertilize the ovum or eggs. The process of storing, freezing, and collecting sperm is called sperm banking. It is also called sperm cryopreservation or sperm freezing. It can be further thawed for use in procedures like in vitro fertilization (IVF) or intrauterine insemination (IUI).

Some of the eminent companies in the North America medical thawing system market include Cardinal Health, Caron Products & Services Inc, Boekel Scientific, Danaher Corporation, FreMon Scientific, etc.

Cardinal Health Inc is a globally integrated healthcare products & services company that offers customized solutions for healthcare systems, hospitals, ambulatory surgery centers, physician offices, clinical laboratories, etc. The company’s medical segment distributes, sources, and manufactures its branded laboratory, surgical, and medical products sold in Asia, Europe, Canada, and the United States. The company has its headquarters in Ohio, the United States.

One of its key products, Plasma Thawing Bath, is designed for use in laboratories and blood banks that require thawing up of four units of FFP (fresh frozen plasma) within 24 hours after Phlebotomy (PF24) for future infusion in a patient.

Report Synopsis:

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.